| Twist Bioscience Garners $61,000,000 Series D Financing | VentureDeal | 01/19/16 | San Francisco |
| With Tensha Purchase, Roche Interest in Bradner Startups Continues | David Holley | 01/11/16 | Boston |
| Iconic Therapeutics Secures $40,000,000 Series C Financing Round | VentureDeal | 01/11/16 | San Francisco |
| East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More | Ben Fidler | 01/08/16 | Boston |
| C4 Therapeutics Lands $73,000,000 Series A Round | VentureDeal | 01/08/16 | Boston |
| Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup | Ben Fidler | 01/07/16 | Boston |
| Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials | Ben Fidler | 01/04/16 | Boston |
| Scholar Rock Lands $36,000,000 Series B Financing Round | VentureDeal | 01/04/16 | Boston |
| Axonics Modulation Technologies Garners $38,500,000 Series B Funding | VentureDeal | 12/21/15 | San Diego |
| Months After Postponed IPO, Gelesis Nabs $31.5M And a New Investor | Ben Fidler | 12/18/15 | Boston |
| Gelesis Garners $31,500,000 New Financing Round | VentureDeal | 12/18/15 | Boston |
| ImmuneXcite Garners $8,600,000 Series A Financing Round | VentureDeal | 12/11/15 | Boston |
| Audentes Therapeutics Garners $65,000,000 Series C Funding | VentureDeal | 10/14/15 | San Francisco |
| Corvus Pharmaceuticals Receives $75,000,000 Series B Funding | VentureDeal | 09/30/15 | San Francisco |
| Proteostasis Therapeutics Lands $37,000,000 Series B Funding | VentureDeal | 09/09/15 | Boston |
| At Summer’s End, Can Crossover Winds Stay At Biotech’s Back? | Alex Lash | 09/01/15 | National |
| New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try | Ben Fidler | 08/24/15 | Boston |
| Syndax Pharmaceuticals Garners $80,000,000 New Financing | VentureDeal | 08/24/15 | Boston |
| WaVe Joins the Crossover Party With $66M Series B for RNA Drugs | Ben Fidler | 08/18/15 | Boston |
| WAVE Life Sciences Garners $66,000,000 Series B Funding | VentureDeal | 08/18/15 | Boston |
| Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers | Ben Fidler | 08/11/15 | New York |
| AnaptysBio Receives $40,000,000 Series D Funding | VentureDeal | 07/16/15 | San Diego |
| With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect | Ben Fidler | 04/30/15 | San Francisco |
| Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology | Ben Fidler | 04/23/15 | Boston |
